Prognostic factors including neoadjuvant chemotherapy in Mexican children with neuroblastoma

Clinical and Translational Oncology

Volumn 7, Issue 1, 2005, Pages 12-17

  Olaya Vargas, Alberto ^a   Rivera Luna, Roberto ^a   Cárdenas Cardós, Rocío ^a   Toledo, Araceli Castellanos ^a   González, Óscar Alberto Pérez ^a   Castro, Julieta Robles ^a   Elvir, Carlos Calderón ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Neoadjuvant chemotherapy; Neuroblastoma; Prognostic factors

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ARTICLE; CHILD; COMPARATIVE STUDY; FEMALE; HUMAN; INFANT; MALE; MEXICO; NEUROBLASTOMA; PRESCHOOL CHILD; PROGNOSIS; RETROSPECTIVE STUDY;

ADOLESCENT; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MEXICO; NEUROBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 22244464894     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/BF02710020     Document Type: Article

References (27)

1. DuBois SG, Kalika Y, Lukens JN, et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 1999;21:181-9. (Pubitemid 30306028)
2. Nonane J, Pritchard J, Morris Jones PH . Stage II neuroblastoma. Adverse prognostic significance of linph node involvement. Arc Dis Child 1982;57:438.
3. Brook FB, Raafat R, Elldeeb BB. Histologic and inmunohistochemical investigation of neuroblastomas and correlation with prognosis. Hum Pathol 1988; 19:879.
4. Martínez AA. Neuroblastoma. In: Rivera-Luna R. Diagnóstico del niño con cáncer. España: Mosby, 1994;p.219.
5. Ribera-Luna R, Martínez G, Martinez A. Neuroblastoma. Experiencia del INP. Cancerología 1988;34:673.
6. Berthold GM. Overview: Biology of Neuroblastoma. In: Pochedly C, editor. Neuroblastoma: tumor biology and therapy. Boca Raton, FL: CRC Press, 1990;p.1.
7. Brodeur GM, Azar C, Brother M, et al. Neuroblastoma: effect of genetic factors on prognosis and treatment. Cancer 1992;70:1685-94.
8. Chan HS, Gallie BL, DeBoer G. MYCN protein expression as a predictor of neuroblastoma prognosis. Clin Cancer Res 1997;3:1699-706. (Pubitemid 27444707)
9. Bordow SB, Norris MD, Haber PS. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol 1998;16:3286-94. (Pubitemid 28481623)
10. Contador MP, Johnston S, Smith EI, et al. Lymph node sampling in localized neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg 1999;34:967-74. (Pubitemid 29277915)
11. Yoshinobo H, Haruhiko N. Fifteen year's experience of neuroblastoma: a prognostic evaluation according to the Evans and UICC staging. J Pediatr Surg 1990;25:326.
12. Hata Y, Naito H, Sasaki J. Fifteen year's experience of neuroblastoma: a prognosis evaluation according to the Evans an UICC staging systems. J Pediatr Surg 1990;25:326.
13. Berthold F, Trechow R, Utsch S. Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 1992;14:207.
14. Berthold F, Harms D, Lampert F. Risk factors in neuroblastoma of infants. Contrib Oncol 1990;41:101.
15. Coldman MA, Alwood H. Neuroblastoma, influence of age at diagnossis, stage, tumor site, and sex on prognosis. Cancer 1980;46: 1896.
16. Matthay KK, Perez C, Seeger RC, et al. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol 1998;16:1256-64. (Pubitemid 28175737)
17. Hayes FA, Smith E. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 2nd edition. Philadelphia: Lippincott, 1993; p.739.
18. Olshan AF, Bunin GR. Epidemiology of neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, et al, editors. Neuroblastoma. Amsterdam: Elsevier Science, 2000; p.33-9.
19. DeBernardi B, Roger D, Carli M. Localized neuroblastoma. Surgical and pathologic staging. Cancer 1987;60:1066.
20. Kiely EM. The surgical challenge of neuroblastoma. J Pediatr Surg 1994;29:128-33. (Pubitemid 24068613)
21. Joshi W, Carton AB, Atshuler G. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study os 211 cases from the pediatric oncology group. Cancer 1992;69:2197.
22. Silber JH, Evans EA, Fridman M. Models to predict outcome from childhood neuroblastoma: the rol of serum ferritin and tumor histology. Cancer Res 1991;51:1426.
23. Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and age- linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16. (Pubitemid 14055221)
24. Garret MB, Azar C, Brodeur M, Kaufman B. Neuroblastoma, effect of genetic factors on prognosis and treatment. Cancer 1992;70:1685.
25. Taylor CPF, McGuckin AG, Brown NP. Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumor imprints and bone marrow smears. Br J Cancer 1994;69:445.
26. Brodeur GM, Seeger RC, Barret A. International criteria for diagnosis, staging ans respose to tratment an patients with neuroblastoma. J Clin Oncol 1988;6:1874.
27. Franks LM, Bollen A, Seeger RC, et al. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 1997;79:2028-35. (Pubitemid 27200389)